van der Reijden BA - Search Results

1

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss T, Izzo B, Nomdedeu J, van der Heijden A, van der Reijden BA, Jansen JH, van der Velden VH, Ommen H, Preudhomme C, Saglio G, Grimwade D. Cilloni D, et al. Among authors: van der velden vh, van der reijden ba, van der heijden a. J Clin Oncol. 2009 Nov 1;27(31):5195-201. doi: 10.1200/JCO.2009.22.4865. Epub 2009 Sep 14. J Clin Oncol. 2009. PMID: 19752335

2

Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial.

Verweij L, Ector GICG, Smit Y, van Vlijmen B, van der Reijden BA, Hermens RPMG, Blijlevens NMA. Verweij L, et al. Among authors: van der reijden ba, van vlijmen b. BMC Health Serv Res. 2023 Mar 8;23(1):228. doi: 10.1186/s12913-023-09153-9. BMC Health Serv Res. 2023. PMID: 36890512 Free PMC article. Clinical Trial.

3

Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses.

Severens JF, Karakaslar EO, van der Reijden BA, Sánchez-López E, van den Berg RR, Halkes CJM, van Balen P, Veelken H, Reinders MJT, Griffioen M, van den Akker EB. Severens JF, et al. Among authors: van der reijden ba. Leukemia. 2024 Apr;38(4):751-761. doi: 10.1038/s41375-024-02137-6. Epub 2024 Feb 15. Leukemia. 2024. PMID: 38360865

4

Improvement, Implementation, and Evaluation of the CMyLife Digital Care Platform: Participatory Action Research Approach.

Verweij L, Metsemakers SJJPM, Ector GICG, Rademaker P, Bekker CL, van Vlijmen B, van der Reijden BA, Blijlevens NMA, Hermens RPMG. Verweij L, et al. Among authors: van der reijden ba, van vlijmen b. J Med Internet Res. 2023 Sep 15;25:e45259. doi: 10.2196/45259. J Med Internet Res. 2023. PMID: 37713242 Free PMC article.

5

Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.

Heuts BMH, Arza-Apalategi S, Alkema SG, Tijchon E, Jussen L, Bergevoet SM, van der Reijden BA, Martens JHA. Heuts BMH, et al. Among authors: van der reijden ba. Cells. 2023 Apr 20;12(8):1195. doi: 10.3390/cells12081195. Cells. 2023. PMID: 37190104 Free PMC article.

6

Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The Netherlands.

van der Reijden BA, Bloomfield CD, Touw IP, Jansen JH. van der Reijden BA, et al. Leukemia. 1997 Dec;11(12):2217-9. Leukemia. 1997. PMID: 9447846

7

Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood.

Gomez E, van der Poel SC, Jansen JH, van der Reijden BA, Lowenberg B. Gomez E, et al. Among authors: van der reijden ba, van der poel sc. Blood. 1998 Mar 15;91(6):2208-9. Blood. 1998. PMID: 9490710 Free article. No abstract available.

8

Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).

de Vetten MP, Jansen JH, van der Reijden BA, Berger MS, Zijlmans JM, Löwenberg B. de Vetten MP, et al. Among authors: van der reijden ba. Br J Haematol. 2000 Oct;111(1):277-9. doi: 10.1046/j.1365-2141.2000.02402.x. Br J Haematol. 2000. PMID: 11091212 Free article.

9

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

Van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Löwenberg B, Jansen JH. Van der Reijden BA, et al. Among authors: van der poel s. Hematol J. 2001;2(3):206-9. doi: 10.1038/sj.thj.6200103. Hematol J. 2001. PMID: 11920247

10

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.

van der Reijden BA, Simons A, Luiten E, van der Poel SC, Hogenbirk PE, Tönnissen E, Valk PJ, Löwenberg B, De Greef GE, Breuning MH, Jansen JH. van der Reijden BA, et al. Among authors: van der poel sc. Br J Haematol. 2002 Aug;118(2):411-8. doi: 10.1046/j.1365-2141.2002.03738.x. Br J Haematol. 2002. PMID: 12139724 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters